"But Those [Lipid] Nanoparticles Can Lead To Dangerous Side Effects, Especially If A Patient Has To Take Repeated Doses Over Months Or Years"

Quote from a story following an interview in 2016 with Stéphane Bancel, CEO of Moderna

It has been two years, six months, and eighteen days (930 total days) since the administration of my employer, the University of Guelph, banned me from accessing my office and laboratory. I spoke truths about COVID-19 when much of the world was not ready to hear them. As the University of Guelph still expects me to work, I would like to have access to my work spaces. Segregation makes me feel less than human.

- B. Bridle -

Please share this information with anyone considering taking another dose of a modified RNA shot.

Did you know that the lipid nanoparticles (LNPs) used to make Moderna’s and Pfizer’s COVID-19 shots were re-purposed to serve as vaccine platforms? They were originally intended to be a delivery mechanism for drugs and/or gene therapies. The problem is that the LNPs were toxic if administered multiple times. And treatment of cancers and other diseases with LNPs containing drugs or gene therapies required multi-dosing protocols.

For this reason, several companies abandoned the use of LNPs. Moderna decided to change course and use LNPs as a vaccine delivery system. Why? Because they understood that an ideal vaccine is one that requires a single dose and then the person is protected from getting the disease for the rest of their life. If you don’t believe me, please review Health Canada’s official definition of an ideal vaccine here. This is the relevant quote…

“An ideal vaccine is: safe with minimal adverse effects; effective in providing lifelong protection against disease after a single dose that can be administered at birth; inexpensive; stable during shipment and storage; and easy to administer.“

So, problem solved. A good LNP-based vaccine would require only a single dose. No multi-dosing = none of the toxicities known to be associated with multiple administrations of LNPs.

But, don’t take my word for it. Instead, I defer to a journalist that interviewed Stéphane Bancel. He is the Chief Executive Officer of the American company Moderna, which makes one of the two available modified RNA COVID-19 shots. A story was published on September 13, 2016, after an interview with him. Please heed his serious concerns about the LNPs that his company is using. Here are quotes from the story about the interview; brace yourself…

“In nature, mRNA molecules function like recipe books, directing cellular machinery to make specific proteins. Moderna believes it can play that system to its advantage by using synthetic mRNA to compel cells to produce whichever proteins it chooses. In effect, the mRNA would turn cells into tiny drug factories. It’s highly risky. Big pharma companies had tried similar work and abandoned it because it’s exceedingly hard to get RNA into cells without triggering nasty side effects.”

“Delivery – actually getting RNA into cells – has long bedeviled the whole field. On their own, RNA molecules have a hard time reaching their targets. They work better if they’re wrapped up in a delivery mechanism, such as nanoparticles made of lipids. But those nanoparticles can lead to dangerous side effects, especially if a patient has to take repeated doses over months or years. Novartis abandoned the related realm of RNA interference over concerns about toxicity, as did Merck and Roche.”

I encourage you to re-read the two quotes above a couple of times. Let them sink in. Then think about the billions of people around the world that have taken multiple doses. Isn’t it astonishing?

Why did Bancel not remind the world of these concerns in 2020 when he realized that his ‘vaccine’ was far from ideal and that multiple doses would be required.

I don’t know if it is relevant, but this is the second last sentence in Wikipedia’s description of Stéphane Bancel…

“In April 2020, with the Moderna share price rising on news of imminent phase 2 human trials for its potential COVID-19 vaccine, Bancel's stake of about 9% became worth over $1 billion.“

Also, note that Moderna, which was a small start-up company not all that many years ago would have gone under had its attempt at a LNP-based vaccine not been successful. Moderna was ‘all in’ on this business move.

Remarkably, some people are still eager to get more doses. I have heard of some that have received at least nine doses. This is downright frightening in light of concerns identified after the interview with CEO Bancel, “especially if a patient has to take repeated doses over months or years.“

I would love to know how many legitimate doses Stéphane Bancel has taken of his own COVID-19 shot.

And journalists should ask him to explain the information he relayed in 2016, as presented in the follow-up to his interview.

More doses anyone?

How about more LNP-based shots for other problems, like disease X, in the future?

Please share this widely among your family, friends, and colleagues because everyone deserves the opportunity to make fully informed decisions.

---